ERBB2 and breast carcinoma: The overall expression levels of FABP4 in tumor cells were very low across breast cancer subtypes, and there were no significant differences in FABP4 expression H-score among various subtypes (Fig. 4G), suggesting minimal impact of hormones (e.g. estrogens, progesterone) or growth factor signals (HER2) on FABP4 expression.